tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Mesoblast downgraded to Hold from Buy at Jefferies
The FlyMesoblast downgraded to Hold from Buy at Jefferies
21h ago
MESO
Mesoblast reports Q1 Ryoncil gross revenue $13.2M
PremiumThe Fly
Mesoblast reports Q1 Ryoncil gross revenue $13.2M
1d ago
MESO
Mesoblast Reports Successful Launch of Ryoncil® and Expands Pipeline Efforts
PremiumCompany Announcements
Mesoblast Reports Successful Launch of Ryoncil® and Expands Pipeline Efforts
1d ago
JPMorgan Acquires 5% Stake in Mesoblast Limited
PremiumCompany Announcements
JPMorgan Acquires 5% Stake in Mesoblast Limited
1d ago
Mesoblast Limited Announces Cessation of Securities
PremiumCompany Announcements
Mesoblast Limited Announces Cessation of Securities
5d ago
Mesoblast Limited Announces Quotation of New Securities on ASX
PremiumCompany AnnouncementsMesoblast Limited Announces Quotation of New Securities on ASX
5d ago
JPMorgan Chase Ceases Substantial Holding in Mesoblast
Premium
Company Announcements
JPMorgan Chase Ceases Substantial Holding in Mesoblast
11d ago
JPMorgan Acquires Substantial Stake in Mesoblast Limited
Premium
Company Announcements
JPMorgan Acquires Substantial Stake in Mesoblast Limited
12d ago
Buy Rating for Mesoblast: FDA Alignment and Promising Revascor Data Drive Optimism
PremiumRatings
Buy Rating for Mesoblast: FDA Alignment and Promising Revascor Data Drive Optimism
15d ago
MESO
Mesoblast Aligns with FDA for Revascor Biologics License Application
PremiumCompany Announcements
Mesoblast Aligns with FDA for Revascor Biologics License Application
18d ago
JPMorgan Chase & Co. Reduces Stake in Mesoblast Limited
PremiumCompany Announcements
JPMorgan Chase & Co. Reduces Stake in Mesoblast Limited
23d ago
JPMorgan Becomes Substantial Holder in Mesoblast
PremiumCompany Announcements
JPMorgan Becomes Substantial Holder in Mesoblast
1M ago
JPMorgan Chase & Co. Ceases to be Substantial Holder in Mesoblast Limited
PremiumCompany AnnouncementsJPMorgan Chase & Co. Ceases to be Substantial Holder in Mesoblast Limited
1M ago
Mesoblast gives update on Revascor accelerated approval, Ryoncil label extension
Premium
The Fly
Mesoblast gives update on Revascor accelerated approval, Ryoncil label extension
1M ago
MESO
Mesoblast Advances FDA Approvals for Revascor® and Ryoncil®
Premium
Company Announcements
Mesoblast Advances FDA Approvals for Revascor® and Ryoncil®
1M ago
Vanguard Group Acquires Substantial Stake in Mesoblast Limited
PremiumCompany Announcements
Vanguard Group Acquires Substantial Stake in Mesoblast Limited
1M ago
JPMorgan Becomes Substantial Holder in Mesoblast Limited
PremiumCompany Announcements
JPMorgan Becomes Substantial Holder in Mesoblast Limited
1M ago
Mesoblast Limited Announces Substantial Holding Update
PremiumCompany Announcements
Mesoblast Limited Announces Substantial Holding Update
2M ago
Is MEOBF a Buy, Before Earnings?
PremiumPre-Earnings
Is MEOBF a Buy, Before Earnings?
2M ago
Mesoblast gets years of orphan-drug exclusive approval from FDA for Ryoncil
PremiumThe FlyMesoblast gets years of orphan-drug exclusive approval from FDA for Ryoncil
2M ago
MESO
Mesoblast Secures Seven-Year FDA Orphan-Drug Exclusivity for Ryoncil®
Premium
Company Announcements
Mesoblast Secures Seven-Year FDA Orphan-Drug Exclusivity for Ryoncil®
2M ago
JPMorgan Acquires Substantial Stake in Mesoblast Limited
Premium
Company Announcements
JPMorgan Acquires Substantial Stake in Mesoblast Limited
2M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >